Mogamulizumab-kpkc Intravenous and Optiray
Determining the interaction of Mogamulizumab-kpkc Intravenous and Optiray and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: ioversol
Brand name: Optiray 240, Optiray 300, Optiray 320, Optiray 350, Optiray 160
Synonyms: Ioversol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Optiray 160
- Mogamulizumab-kpkc Intravenous-Optiray 240
- Mogamulizumab-kpkc Intravenous-Optiray 300
- Mogamulizumab-kpkc Intravenous-Optiray 320
- Mogamulizumab-kpkc Intravenous-Optiray 350
- Mogamulizumab-kpkc Intravenous-Optison
- Optiray-Molindone
- Optiray-Mometasone (Oral Inhalation)
- Optiray-Mometasone and Formoterol
- Optiray-Mometasone and formoterol Inhalation
- Optiray-Mometasone Cream
- Optiray-Mometasone Furoate